Abstract:
Background Papillary thyroid carcinoma (PTC) is the most common malignancy of the endocrine system. Growing evidences suggest that circular RNAs (circRNAs) are closely related to the development of tumors. However, few studies to date have assessed the function of circRNAs in PTC.
Objective To construct the circRNA-miRNA-mRNA network of papillary thyroid carcinoma (PTC) patients based on bioinformatics, and explore the regulatory mechanism of circRNA in the prognosis of PTC.
Methods The circRNAs, miRNAs and mRNAs of PTC patients were obtained from Gene Expression Omnibus (GEO) database. The tissue samples of patients were divided into tumor group (circRNA: 6 cases; miRNA: 5 cases; mRNA: 32 cases) and control group (circRNA: 6 cases; miRNA: 5 cases; mRNA: 51 cases), and the differentially expressed circRNAs, miRNAs and mRNAs were screened out respectively to construct circRNA-miRNA-mRNA regulatory network. The transcriptome data and clinicopathological data of PTC patients were downloaded from the Cancer Genome Atlas (TCGA) database, then the differentially expressed mRNAs related to the prognosis of PTC patients were screened by Kaplan-Meier analysis to further construct the circRNA-miRNA-mRNA regulatory network involved in the prognosis of PTC patients.
Results Totally 30 differentially expressed circRNAs, 10 differentially expressed miRNAs and 12 differentially expressed mRNAs were screened out based on the sequencing datasets in GEO database, and the PTC-related circRNA-miRNA-mRNA regulatory network was then successfully constructed. Through the TCGA database, we found that KIT, SFN and SPRY4 were closely related to the prognosis of PTC patients, and subsequently the circRNA-miRNA-mRNA regulatory subnetwork related to the prognosis of PTC was established to clarify the regulatory mechanism of circRNAs in PTC.
Conclusion This study provides references for circRNAs mediating the prognosis of PTC through the ceRNA mechanism, and also provides theoretical evidences and new insights for predicting prognosis and treatment of PTC.